Erythopoietin defficiency and anaemia in multiple system atrophy

Movement Disorders

Volumn 16, Issue 2, 2001, Pages 233-239

  Winkler, Andrea S ^a   Marsden, Joanne ^a   Parton, Matthew ^a   Watkins, Peter J ^a   Chaudhuri, K Ray ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Anaemia; Erythropoietin; Multiple system atrophy; Postural hypotension

Indexed keywords

CREATININE; ERYTHROPOIETIN; HEMOGLOBIN; IRON;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DYSAUTONOMIA; FEMALE; HUMAN; IDIOPATHIC DISEASE; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; REGRESSION ANALYSIS; SHY DRAGER SYNDROME; ANEMIA; AUTONOMIC NEUROPATHY; BLOOD; CARDIOVASCULAR SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART RATE; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANEMIA; AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR SYSTEM; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; FEMALE; HEART RATE; HEMOGLOBINS; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; SEVERITY OF ILLNESS INDEX;

EID: 0035287398     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1063     Document Type: Article

References (33)

1. Krantz SB, Sawyer ST, Sawada KI. The role of erythropoietin in erythroid cell differentiation. In: Koch KM, Kühn K, Nonnast-Daniel B, Scigalla P, eds. Treatment of renal anaemia with recombinant erythropoietin. Contributions to nephrology. Basel: Karger; 1988:25-38.
2. Fried W, Plzak LF, Jacobson LO, Goldwasser E. Studies on erythropoiesis III. Factors controlling erythropoietin production. Proc Soc Exp Biol Med 1954;94:237-241.
3. Schuster SJ, Koury ST, Bohrere M, Salceda S, Caro J. Cellular sites of extra-renal and renal erythropoietin production in anaemic rats. Br J Haematol 1992;81:153-159.
4. Caro J, Brown S, Miller O, Murray T, Erslev AJ. Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979;93:449-458.
5. Eschbach JW, Adamson JW. Modern aspects of pathophysiology in renal anaemia. In: Koch KM, Kühn K, Nonnast-Daniel B, Scigalla P, eds. Treatment of renal anaemia with recombinant erythropoietin. Contributions to nephrology. Basel: Karger;1988:63-71.
6. Macdougall IC. Treatment of renal anaemia with recombinant human erythropoietin. Curr Opin Nephrol Hypertens 1992;1:210-219.
7. Takaku F, Hirashima K, Okinaka S. Effect of bilateral section of the splanchnic nerve on erythropoiesis. Nature 1961;191:500-501.
8. Beynon G. The influence of the autonomic nervous system in the control of erythropoietin secretion in the hypoxic rat. J Physiol 1977;266:347-360.
9. Fink GD, Fisher JW. Stimulation of erythropoiesis by beta adrenergic agonists. II. Mechanism of action. J Pharmacol Exp Ther 1977;202:199-208.
10. Zivny J, Ostadal B, Neuwirt J, Prochazka J, Pelouch V. Effect of beta adrenergic blocking agents on erythropoiesis in rats. J Pharmacol Exp Ther 1983;226:222-225.
11. Quinn N. Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry 1989;suppl:78-89.
12. Quinn N, Marsden CD. The motor disorder of multiple system atrophy. J Neurol Neurosurg Psychiatry 1993;56:1239-1242.
13. Daniel SE. The neuropathology and neurochemistry of multiple system atrophy. In: Bannister R, Mathias CJ, eds. Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford: Oxford University Press; 1992:564-585.
14. Van Dijk JG, Haan J, Zwinderman K, Kremer B, van Hilten BJ, Roos RAC. Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity. J Neurol Neurosurg Psychiatry 1993;56:1090-1095.
15. Wenning GK, Tison F, Shlomo Ben, Daniel E, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147.
16. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, et al. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Autonom Res 1998;8:359-362.
17. Pratt MC, Lewis-Barned NJ, Walker RJ, Bailey RR, Shand BI, Livesey J. Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmacol 1992;34:363-365.
18. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
19. Mathias CJ, Bannister R. Investigation of autonomic disorders. In: Mathias CJ, Bannister R, eds. Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford: Oxford University Press; 1999:169-195.
20. Page MM, Watkins PJ. The heart in diabetes: autonomic neuropathy and cardiomyopathy. In: Tattersall R, ed. Clinics in endocrinology and metabolism. London: WB Saunders; 1977:377-388.
21. American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. In: Robertson D, Low PA, Polinsky RJ, eds. Primer on the autonomic nervous system. San Diego: Academic Press; 1996:334-336.
22. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994;121:181-186.
23. Ando Y, Asahara K, Obayashi K. Autonomic dysfunction and anemia in neurological disorders. J Auton Nerv Syst 1996;61:145-148.
24. Hoeldtke RD, Streeten DHP. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993;329:611-615.
25. Winkler AS, Ejskjaer N, Marsden J, Chaudhuri KR, Watkins PJ. Erythropoietin and haemoglobin in diabetic autonomic neuropathy. Diab Med 1999;16:813-819.
26. Fink GD, Paulo LG, Fisher JW. Effects of β-adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia. J Pharmacol Exp Ther 1975;193:176-181.
27. Chaudhuri K Ray, Thomaides T, Mathias CJ. Abnormality of superior mesenteric artery blood flow responses in human sympathetic failure. J Physiol 1992;457:477-489.
28. Spannhake EW, Fisher JW. Partial inhibition of hypoxia induced erythropoietin production by cholinergic blockade in the dog. Proc Soc Exp Biol Med 1977;156:19-23.
29. Garnick MB, Abels RI, Rudnick SA Raritan NJ. The role of recombinant human erythropoietin in the management associated with acquired immunodeficiency syndrome. In: Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L, eds. Erythropoietin in renal and non-renal anemias. Update on basic research and clinical applications. Contributions to nephrology, vol 88. London: Karger; 1991:282-293.
30. Birgegard G, Gudbjörnsson B, Hällgren R, Wide L. Anemia of chronic inflammatory arthritides: treatment with recombinant erythropoietin. In: Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L, eds. Erythropoietin in renal and non-renal anemias. Update on basic research and clinical applications. Contributions to nephrology, vol 88. London: Karger; 1991:282-293.
31. Means RT Jr, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639-1647.
32. Awerbuch GI. Autonomic function in the early stages of Parkinson's Disease. Int J Neurosci 1992;64:7-14.
33. Braune S, Reinhardt M, Schnitzer R, Riedel A, Lücking CH. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999;53:1020-1025.